𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of minocycline in experimental autoimmune encephalomyelitis

✍ Scribed by Stefan Nessler; Richard Dodel; Alwina Bittner; Stefanie Reuss; Yansheng Du; Bernhard Hemmer; Norbert Sommer

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
65 KB
Volume
52
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased thrombin inhibition in experim
Increased thrombin inhibition in experimental autoimmune encephalomyelitis
✍ Orit Beilin; Dimitrios M. Karussis; Amos D. Korczyn; David Gurwitz; Ramona Arono πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are inflammatory diseases of the central nervous system (CNS). Activated coagulation factors are associated with inflammation and are elevated in the plasma of animals with EAE. Thrombin is a

Role of nerve growth factor in experimen
Role of nerve growth factor in experimental autoimmune encephalomyelitis
✍ LaChelle R. Arredondo; Caishu Deng; Robert B. Ratts; Amy E. Lovett-Racke; David πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

The expression of neural regulatory molecules by immune cells that infiltrate the nervous system upon injury may be a mechanism for cross-regulation between the nervous system and the immune system. Several lines of evidence implicate nerve growth factor (NGF) signaling through its receptors (TrkA a

Regulation of cytokine gene expression i
Regulation of cytokine gene expression in experimental autoimmune encephalomyelitis
✍ Ian M. Zitron; B. Praveen Reddy; Karen E. Gould; Jolie A. Stephanik; Robert H. S πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 774 KB

We previously reported that recovery of Lewis rats from experimental autoimmune encephalomyelitis (EAE) is associated with the appearance of suppressor T cells (Ts). These Ts secrete TGF-beta which down-regulates the production of inflammatory cytokines by the effector T cells that mediate this dise

Axonal protection using flecainide in ex
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
✍ David A. Bechtold; Raju Kapoor; Kenneth J. Smith πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 573 KB

## Abstract Axonal degeneration is a major cause of permanent neurological deficit in multiple sclerosis (MS), but no current therapies for the disease are known to be effective at axonal protection. Here, we examine the ability of a sodium channel–blocking agent, flecainide, to reduce axonal degen